{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:27:25Z","timestamp":1784366845658,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.lfs.2019.116982","type":"journal-article","created":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T17:45:35Z","timestamp":1571507135000},"page":"116982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Pirfenidone alleviates concanavalin A-induced liver fibrosis in mice"],"prefix":"10.1016","volume":"239","author":[{"given":"Mostafa M.","family":"Salah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Abdelghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Aziz H.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salama A.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2019.116982_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Brenner","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2019.116982_bib2","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbadis.2012.11.002","article-title":"Extracellular matrix degradation in liver fibrosis: biochemistry and regulation","volume":"1832","author":"John","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.lfs.2019.116982_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"23","key":"10.1016\/j.lfs.2019.116982_bib4","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","article-title":"Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: an update","volume":"20","author":"Elpek","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.lfs.2019.116982_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","article-title":"Experimental liver fibrosis research: update on animal models, legal issues and translational aspects","volume":"6","author":"Liedtke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"5","key":"10.1016\/j.lfs.2019.116982_bib6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1159\/000445269","article-title":"New developments on the treatment of liver fibrosis","volume":"34","author":"Koyama","year":"2016","journal-title":"Dig. Dis."},{"issue":"2","key":"10.1016\/j.lfs.2019.116982_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3748\/wjg.v18.i2.119","article-title":"Immune mechanisms of Concanavalin A model of autoimmune hepatitis","volume":"18","author":"Wang","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.lfs.2019.116982_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2131\/jts.39.179","article-title":"Dietary fish oil exacerbates concanavalin A induced hepatitis through promoting hepatocyte apoptosis and altering immune cell populations","volume":"39","author":"Xia","year":"2014","journal-title":"J. Toxicol. Sci."},{"issue":"1_suppl","key":"10.1016\/j.lfs.2019.116982_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0023677215572841","article-title":"The concanavalin A model of acute hepatitis in mice","volume":"49","author":"Heymann","year":"2015","journal-title":"Lab. Anim."},{"issue":"2","key":"10.1016\/j.lfs.2019.116982_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3748\/wjg.v18.i2.119","article-title":"Immune mechanisms of Concanavalin A model of autoimmune hepatitis","volume":"18","author":"Wang","year":"2012","journal-title":"World J. Gastroenterol. : WJG"},{"key":"10.1016\/j.lfs.2019.116982_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00043","article-title":"The role of immune and inflammatory cells in idiopathic pulmonary fibrosis","volume":"5","author":"Desai","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.lfs.2019.116982_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2015\/189785","article-title":"Protective effects of N-acetylcysteine in concanavalin A-induced hepatitis in mice","volume":"2015","author":"Wang","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.lfs.2019.116982_bib13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/17512433.2017.1295846","article-title":"Pirfenidone for the treatment of idiopathic pulmonary fibrosis","volume":"10","author":"George","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"1 Suppl","key":"10.1016\/j.lfs.2019.116982_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0023677215572841","article-title":"The concanavalin A model of acute hepatitis in mice","volume":"49","author":"Heymann","year":"2015","journal-title":"Lab. Anim."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2019.116982_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.semdp.2006.11.006","article-title":"Special stains in diagnostic liver pathology","volume":"23","author":"Lefkowitch","year":"2006","journal-title":"Semin. Diagn. Pathol."},{"issue":"2","key":"10.1016\/j.lfs.2019.116982_bib16","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3892\/mmr.2014.2267","article-title":"Measurement of hydroxyproline in collagen with three different methods","volume":"10","author":"Qiu","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2019.116982_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40139-015-0093-z","article-title":"TNFalpha in liver fibrosis","volume":"3","author":"Yang","year":"2015","journal-title":"Curr Pathobiol Rep"},{"issue":"Suppl 1","key":"10.1016\/j.lfs.2019.116982_bib18","first-page":"S54","article-title":"TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring","volume":"15","author":"Cutroneo","year":"2007","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.lfs.2019.116982_bib19","series-title":"Biomarkers in Liver Disease","first-page":"471","article-title":"Hydroxyproline as a biomarker in liver disease","author":"Gabr","year":"2017"},{"issue":"5","key":"10.1016\/j.lfs.2019.116982_bib20","first-page":"940","article-title":"Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease","volume":"23","author":"Arthur","year":"1999","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"7","key":"10.1016\/j.lfs.2019.116982_bib21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.lfs.2019.116982_bib22","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"Czaja","year":"2014","journal-title":"World J. Gastroenterol. : WJG"},{"issue":"2","key":"10.1016\/j.lfs.2019.116982_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2131\/jts.39.179","article-title":"Dietary fish oil exacerbates concanavalin A induced hepatitis through promoting hepatocyte apoptosis and altering immune cell populations","volume":"39","author":"Xia","year":"2014","journal-title":"J. Toxicol. Sci."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2019.116982_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejphar.2013.09.058","article-title":"Fenofibrate A peroxisome proliferator activated receptor-alpha agonist treatment ameliorates Concanavalin A-induced hepatitis in rats","volume":"721","author":"Mohamed","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2019.116982_bib25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1139\/cjpp-2014-0085","article-title":"Hepatoprotective effects of early pentoxifylline administration on hepatic injury induced by concanavalin A in rat","volume":"92","author":"Mohamed","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2019.116982_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2567.2007.02672.x","article-title":"Interferon-\u03b2 reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects","volume":"122","author":"Tanabe","year":"2007","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.lfs.2019.116982_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/hep4.1133","article-title":"Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: case report and mini\u2010review of the literature","volume":"2","author":"Verma","year":"2018","journal-title":"Hepatol. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2019.116982_bib28","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.3390\/ijms150610578","article-title":"Molecular mechanism and treatment of viral hepatitis-related liver fibrosis","volume":"15","author":"Su","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2019.116982_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00042737-200402000-00001","article-title":"How can transforming growth factor beta be targeted usefully to combat liver fibrosis?","volume":"16","author":"Shek","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2019.116982_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00159","article-title":"Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?","volume":"7","author":"Chin","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.lfs.2019.116982_bib31","doi-asserted-by":"crossref","first-page":"L824","DOI":"10.1152\/ajplung.00350.2015","article-title":"alpha-Smooth muscle actin is an inconsistent marker of fibroblasts responsible for force-dependent TGFbeta activation or collagen production across multiple models of organ fibrosis","volume":"310","author":"Sun","year":"2016","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.lfs.2019.116982_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7113-8_1","article-title":"Human fibrotic diseases: current challenges in fibrosis research","volume":"1627","author":"Rosenbloom","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.lfs.2019.116982_bib33","series-title":"Hydroxyproline as a Biomarker in Liver Disease","first-page":"1","author":"Gabr","year":"2016"},{"issue":"4","key":"10.1016\/j.lfs.2019.116982_bib34","first-page":"10","article-title":"Assessment of serum hydroxyproline and osteopontin as noninvasive markers of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection","volume":"24","author":"Sabry","year":"2015","journal-title":"Egypt. J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.lfs.2019.116982_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/abbs\/gmq129","article-title":"Texture analysis of liver fibrosis microscopic images: a study on the effect of biomarkers","volume":"43","author":"Amin","year":"2011","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"5","key":"10.1016\/j.lfs.2019.116982_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"Carpino","year":"2005","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.lfs.2019.116982_bib37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2013.08.015","article-title":"Different collagen types show distinct rates of increase from early to late stages of hepatitis C\u2013related liver fibrosis","volume":"45","author":"Chen","year":"2014","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.lfs.2019.116982_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/03008208909103901","article-title":"Collagens of normal and cirrhotic human liver","volume":"23","author":"Aycock","year":"1989","journal-title":"Connect. Tissue Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.116982_bib39","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41598-017-00671-1","article-title":"TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice","volume":"7","author":"Thiele","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519309099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519309099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:35:14Z","timestamp":1758400514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519309099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":39,"alternative-id":["S0024320519309099"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116982","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pirfenidone alleviates concanavalin A-induced liver fibrosis in mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116982"}}